Literature DB >> 7901583

Risk of extrahepatic bileduct cancer after cholecystectomy.

A Ekbom1, C C Hsieh, J Yuen, D Trichopoulos, J K McLaughlin, S J Lan, H O Adami.   

Abstract

The aetiology of cancer of the extrahepatic bile duct is unknown. Gallstones have been proposed to be a risk factor on the basis of ecological and epidemiological evidence. As gallstones are formed in the gallbladder, the occurrence of extrahepatic bileduct cancer in patients after cholecystectomy is of interest. All patients (62,734) who had had a cholecystectomy during 1965-1983 within the Uppsala Health Care Region, Sweden, were followed up to the end of 1987. Excluding the first year of follow-up, 23 cancers of the extrahepatic bileduct occurred vs 26.3 expected for a standardised incidence ratio (SIR) of 0.88 (95% confidence interval [CI] 0.56-1.31). 10 years or more after operation there was a greater reduction of risk (SIR = 0.27; 95% CI 0.06-0.80). Similar patterns were observed for men and women, and among patients who had undergone cholecystectomy only compared with those who had had their common bileducts explored. To assess surveillance bias the incidence of primary liver cancer was also analysed: SIR = 1.15; 95% CI 0.91-1.44 overall, and 10 years or more after cholecystectomy SIR = 0.98; 95% CI 0.66-1.40. This study shows a reduced risk of extrahepatic bileduct cancer 10 or more years after cholecystectomy, indicating that gallstones may be a cause of this cancer.

Entities:  

Mesh:

Year:  1993        PMID: 7901583     DOI: 10.1016/0140-6736(93)92359-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  17 in total

1.  Effects of radical cholecystectomy on nutritional and immune status in patients with gallbladder carcinoma.

Authors:  Xing-Yuan Jiao; Jing-Sen Shi; Jian-Sheng Wang; Yi-Jun Yang; Ping He
Journal:  World J Gastroenterol       Date:  2000-06       Impact factor: 5.742

Review 2.  Photodynamic therapy in the biliary tract.

Authors:  M Ortner
Journal:  Curr Gastroenterol Rep       Date:  2001-04

3.  Cholangiocarcinoma in the distal bile duct: a probable etiologic association with choledocholithiasis.

Authors:  Masako Nishimura; Shigeyuki Naka; Kazuyoshi Hanazawa; Toru Tani; Masanobu Fukami; Shinta Okada; Yoshihide Fujiyama
Journal:  Dig Dis Sci       Date:  2005-11       Impact factor: 3.199

Review 4.  Gastroenterology--II: Small and large bowel, pancreas and biliary system.

Authors:  M C Bateson
Journal:  Postgrad Med J       Date:  1994-09       Impact factor: 2.401

5.  Risk factors for hilar cholangiocarcinoma: a case-control study in China.

Authors:  Wen-Ke Cai; Hui Sima; Ben-Dong Chen; Guang-Shun Yang
Journal:  World J Gastroenterol       Date:  2011-01-14       Impact factor: 5.742

6.  Gallstones and the Risk of Gallbladder Cancer Mortality: A Cohort Study.

Authors:  Seungho Ryu; Yoosoo Chang; Kyung Eun Yun; Hyun-Suk Jung; Jun Ho Shin; Hocheol Shin
Journal:  Am J Gastroenterol       Date:  2016-08-30       Impact factor: 10.864

7.  Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study.

Authors:  Tania M Welzel; Barry I Graubard; Hashem B El-Serag; Yasser H Shaib; Ann W Hsing; Jessica A Davila; Katherine A McGlynn
Journal:  Clin Gastroenterol Hepatol       Date:  2007-08-06       Impact factor: 11.382

8.  Risk factors for extrahepatic bile duct cancers: Los Angeles County, California (USA).

Authors:  W H Chow; J K McLaughlin; H R Menck; T M Mack
Journal:  Cancer Causes Control       Date:  1994-05       Impact factor: 2.506

9.  Risk of hepato-biliary cancer after cholecystectomy: a nationwide cohort study.

Authors:  Wei-Yu Kao; Chian-Yaw Hwang; Chien-Wei Su; Yun-Ting Chang; Jiing-Chyuan Luo; Ming-Chih Hou; Han-Chieh Lin; Fa-Yauh Lee; Jaw-Ching Wu
Journal:  J Gastrointest Surg       Date:  2012-11-27       Impact factor: 3.452

10.  The antecedents of biliary cancer: a primary care case-control study in the United Kingdom.

Authors:  M J Grainge; J West; M Solaymani-Dodaran; G P Aithal; T R Card
Journal:  Br J Cancer       Date:  2008-11-18       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.